Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs.
Saved in:
| Title: | Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs. |
|---|---|
| Authors: | Reddy NR; UCSF Cell Design Institute, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Maachi H; Diabetes Center, University of California, San Francisco, San Francisco, CA, USA., Xiao Y; UCSF Cell Design Institute, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.; Diabetes Center, University of California, San Francisco, San Francisco, CA, USA., Simic MS; UCSF Cell Design Institute, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Yu W; UCSF Cell Design Institute, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Tonai Y; UCSF Cell Design Institute, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Cabanillas DA; UCSF Cell Design Institute, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Serrano-Wu E; UCSF Cell Design Institute, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA., Pauerstein PT; UCSF Cell Design Institute, University of California, San Francisco, San Francisco, CA, USA.; Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA., Tamaki W; UCSF CoLabs, University of California, San Francisco, San Francisco, CA, USA., Allen GM; UCSF Cell Design Institute, University of California, San Francisco, San Francisco, CA, USA.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Parent AV; Diabetes Center, University of California, San Francisco, San Francisco, CA, USA., Hebrok M; Diabetes Center, University of California, San Francisco, San Francisco, CA, USA., Lim WA; UCSF Cell Design Institute, University of California, San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. |
| Source: | Science (New York, N.Y.) [Science] 2024 Dec 06; Vol. 386 (6726), pp. eadl4793. Date of Electronic Publication: 2024 Dec 06. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
